These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 35748739)
21. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. Ahrendt SA; Chow JT; Xu LH; Yang SC; Eisenberger CF; Esteller M; Herman JG; Wu L; Decker PA; Jen J; Sidransky D J Natl Cancer Inst; 1999 Feb; 91(4):332-9. PubMed ID: 10050866 [TBL] [Abstract][Full Text] [Related]
22. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants. Razavi P; Li BT; Brown DN; Jung B; Hubbell E; Shen R; Abida W; Juluru K; De Bruijn I; Hou C; Venn O; Lim R; Anand A; Maddala T; Gnerre S; Vijaya Satya R; Liu Q; Shen L; Eattock N; Yue J; Blocker AW; Lee M; Sehnert A; Xu H; Hall MP; Santiago-Zayas A; Novotny WF; Isbell JM; Rusch VW; Plitas G; Heerdt AS; Ladanyi M; Hyman DM; Jones DR; Morrow M; Riely GJ; Scher HI; Rudin CM; Robson ME; Diaz LA; Solit DB; Aravanis AM; Reis-Filho JS Nat Med; 2019 Dec; 25(12):1928-1937. PubMed ID: 31768066 [TBL] [Abstract][Full Text] [Related]
23. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients. Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127 [TBL] [Abstract][Full Text] [Related]
24. Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC. Wu Z; Yang Z; Li CS; Zhao W; Liang ZX; Dai Y; Zhu Q; Miao KL; Cui DH; Chen LA Cancer Med; 2019 Mar; 8(3):910-919. PubMed ID: 30767431 [TBL] [Abstract][Full Text] [Related]
25. The Diagnostic Utility of Cell-Free DNA from Ex Vivo Bronchoalveolar Lavage Fluid in Lung Cancer. Otake S; Goto T; Higuchi R; Nakagomi T; Hirotsu Y; Amemiya K; Oyama T; Mochizuki H; Omata M Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406535 [TBL] [Abstract][Full Text] [Related]
26. Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma. Lasseter K; Nassar AH; Hamieh L; Berchuck JE; Nuzzo PV; Korthauer K; Shinagare AB; Ogorek B; McKay R; Thorner AR; Lee GM; Braun DA; Bhatt RS; Freedman M; Choueiri TK; Kwiatkowski DJ Genet Med; 2020 Aug; 22(8):1366-1373. PubMed ID: 32341571 [TBL] [Abstract][Full Text] [Related]
27. Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients. Tsui DWY; Cheng ML; Shady M; Yang JL; Stephens D; Won H; Srinivasan P; Huberman K; Meng F; Jing X; Patel J; Hasan M; Johnson I; Gedvilaite E; Houck-Loomis B; Socci ND; Selcuklu SD; Seshan VE; Zhang H; Chakravarty D; Zehir A; Benayed R; Arcila M; Ladanyi M; Funt SA; Feldman DR; Li BT; Razavi P; Rosenberg J; Bajorin D; Iyer G; Abida W; Scher HI; Rathkopf D; Viale A; Berger MF; Solit DB Genome Med; 2021 May; 13(1):96. PubMed ID: 34059130 [TBL] [Abstract][Full Text] [Related]
28. False-Positive Plasma Genotyping Due to Clonal Hematopoiesis. Hu Y; Ulrich BC; Supplee J; Kuang Y; Lizotte PH; Feeney NB; Guibert NM; Awad MM; Wong KK; Jänne PA; Paweletz CP; Oxnard GR Clin Cancer Res; 2018 Sep; 24(18):4437-4443. PubMed ID: 29567812 [No Abstract] [Full Text] [Related]
29. Bronchoalveolar Lavage as Potential Diagnostic Specimens to Genetic Testing in Advanced Nonsmall Cell Lung Cancer. Lin X; Cai Y; Zong C; Chen B; Shao D; Cui H; Li Z; Xu P Technol Cancer Res Treat; 2023; 22():15330338231202881. PubMed ID: 37743841 [No Abstract] [Full Text] [Related]
30. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients. Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370 [TBL] [Abstract][Full Text] [Related]
31. Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study. Ng CKY; Di Costanzo GG; Tosti N; Paradiso V; Coto-Llerena M; Roscigno G; Perrina V; Quintavalle C; Boldanova T; Wieland S; Marino-Marsilia G; Lanzafame M; Quagliata L; Condorelli G; Matter MS; Tortora R; Heim MH; Terracciano LM; Piscuoglio S Ann Oncol; 2018 May; 29(5):1286-1291. PubMed ID: 29509837 [TBL] [Abstract][Full Text] [Related]
32. Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing. Chen KZ; Lou F; Yang F; Zhang JB; Ye H; Chen W; Guan T; Zhao MY; Su XX; Shi R; Jones L; Huang XF; Chen SY; Wang J Sci Rep; 2016 Aug; 6():31985. PubMed ID: 27555497 [TBL] [Abstract][Full Text] [Related]
33. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer. Ai B; Liu H; Huang Y; Peng P Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821 [TBL] [Abstract][Full Text] [Related]
34. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer. Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267 [TBL] [Abstract][Full Text] [Related]
35. Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid. van der Sluis K; van Sandick JW; Vollebergh MA; van Dieren JM; Hugen N; Hartemink KJ; Veenhof AAFA; Verhoeven E; van den Berg JG; Snaebjornsson P; Noe M; van Wezel T; Boelens MC; Kodach LL Oncogene; 2024 Jun; 43(24):1877-1882. PubMed ID: 38654110 [TBL] [Abstract][Full Text] [Related]
36. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients. Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027 [TBL] [Abstract][Full Text] [Related]
37. Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer. Takai E; Totoki Y; Nakamura H; Kato M; Shibata T; Yachida S Adv Exp Med Biol; 2016; 924():13-17. PubMed ID: 27753011 [TBL] [Abstract][Full Text] [Related]
38. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. Ganesamoorthy D; Robertson AJ; Chen W; Hall MB; Cao MD; Ferguson K; Lakhani SR; Nones K; Simpson PT; Coin LJM BMC Cancer; 2022 Jan; 22(1):85. PubMed ID: 35057759 [TBL] [Abstract][Full Text] [Related]
39. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients. Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758 [TBL] [Abstract][Full Text] [Related]
40. Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA. Otsubo K; Sakai K; Takeshita M; Harada D; Azuma K; Ota K; Akamatsu H; Goto K; Horiike A; Kurata T; Nakagaki N; Nosaki K; Iwama E; Nakanishi Y; Nishio K; Okamoto I Oncologist; 2019 Aug; 24(8):1022-1026. PubMed ID: 31023862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]